HEALTHEQUITY INC (HQY)
Health Care · Healthcare benefits administration and tax-advantaged savings account services · NASDAQ
HealthEquity is the largest HSA administrator by account count, managing $36.5 billion in consumer healthcare savings through technology-enabled services integrated with the broader health and benefits ecosystem.
What HEALTHEQUITY INC does
HealthEquity is a technology-enabled services company that manages health savings accounts (HSAs) and other consumer-directed benefits (CDBs) such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA, and commuter benefits. The company provides a platform for consumers to save, spend, and invest healthcare dollars, integrated with employer-provided benefit programs and insurance ecosystems. HealthEquity serves as an IRS-approved non-bank custodian and generates revenue through administration service fees, interest on custodial cash deposits, and payment card interchange fees.
Themes: Healthcare benefits administration, Tax-advantaged health savings, Consumer-directed healthcare, Health savings account management, Benefits platform / ecosystem
Fundamentals
- Price$105.41 as of 2026-08-21 close
- Market cap$8.8B as of 2026-08-21
- 1-year return+15.8% 2025-08-21 close $91.06 → 2026-08-21 close $105.41
- P/E38.26 as of 2026-08-24
- Net margin+17.3% as of 2026-08-24
- Gross margin+70.7% as of 2026-08-24
- ROE+10.9% as of 2026-08-24
- Debt / equity0.46 as of 2026-08-24
- Revenue growth (YoY)+7.6% as of 2026-08-24
- Revenue CAGR (3y)+15.1% SEC XBRL
- Beta0.24 as of 2026-08-24
- Last reported earnings2026-05-28 SEC EDGAR Form 8-K (Item 2.02)
How HQY compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 10% 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2026
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
HQY is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
58.9 #272 of 1,704 scored · #57 of 240 in Health Care
Trend 77th: the price is 12% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; setup 56th: day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move; weakest is catalysts 47th: analysts' average price target is unchanged from the prior reading.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which HQY reported a dividend payment is FY2015, while its reported financial statements run through FY2026. Coverage is therefore not assessed for the latest year — an FY2015 ratio would not describe HQY today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2015) is older than the latest year of reported financial statements (FY2026), so any ratio would describe an out-of-date year. Informational only — not financial advice.
How HEALTHEQUITY INC looks technically
HEALTHEQUITY INC (HQY) is trading 18.0% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 25 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 37, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 61, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative). It made a new 20-day high about 10 trading days ago. It is 2.1% below its 52-week high (its highest price of the past year). Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move.
Trend
9
| Distance from the 200-day | it is trading 18.0% above its 200-day average, the long-term trend line — a longer-term uptrend | +18.0% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $96.58 | $96.58 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $89.36 | $89.36 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 11 calendar days ago — the swings before that are what the structure reading is measured on | 11 sessions |
| Wave structure | its recent swings can be read as a completed three-part upward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes above 107.62. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a five-part sequence in leg 4. | possible three-wave upward correction, complete (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 25 trading days ago — a "golden cross", a bullish long-term signal | 25 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 18.0% above | +18.0% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 37, with buyers in control | 37.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 61, neither overbought (above 70) nor oversold (below 30) | 61.5 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($101.58 to $107.62) — its "stochastic" reading is 63 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 63.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $107.62 | $107.62 |
|---|---|---|
| From the 52-week high | it is 2.1% below its 52-week high (its highest price of the past year) | -2.0% |
| Above the 52-week low | it is 44.9% above its 52-week low (its lowest price of the past year) | +44.9% |
| Below the 52-week high | it is 2.1% below its highest point of the past year | 2.0% |
| Since a 20-day breakout | it made a new 20-day high about 10 trading days ago | 10 sessions |
| Since a 55-day breakout | it made a new 55-day high about 10 trading days ago | 10 sessions |
| All-time high | its highest closing price on record is $116.65 (set on 2025-06-05) | $116.65 |
| Given back of the 52-week move | over the past year its closes ranged ($73.21 to $106.79), and it has given back only a small part of its rise from last year’s low — 4% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $84.96 to $86.04. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 4.1% |
| From the all-time high | it is 9.6% below its all-time high | -9.6% |
| Nearest price level | it is trading 1.0% below a resistance level at $106.50 — a price it turned at four times since 2024-11-25, most recently on 2026-08-10. Since 2024-08-21 it has 11 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.0% |
| All-time low | its lowest closing price on record is $15.80 (set on 2016-02-05) | $15.80 |
| Above the all-time low | it is 567.2% above its all-time low | +567.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move | 3rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.82 between its high and its low — about 2.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.82 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $99.86 and $107.61 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $99.86 – $103.74 – $107.61 |
| Typical daily range (% of price) | its price moves about 2.7% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.7% |
| Stretch from the 200-day average | it is trading 5.7 daily ranges above its 200-day average price (18.0% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 5.7 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.86× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.3% |
|---|---|---|
| Gap filled | a 2.3% gap down opened on 2026-07-21 has been "filled" 23 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 23 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 4 sessions in a row, a +3.01% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 4 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 5.5 percentage points (the stock gained 7.8% while the market gained 2.3%) | +5.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 18.9 percentage points (the stock gained 22.0% while the market gained 3.1%) | +18.9% |
| vs market, 6 months | over the past 6 months this stock beat the market by 22.5 percentage points (the stock gained 33.6% while the market gained 11.1%) | +22.5% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 4.7 percentage points (the stock gained 15.8% while the market gained 20.5%) | -4.7% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 13% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.9% of the share price. | +13.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 22% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $86.44 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +21.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 12% above the average price paid since it last reported on 2026-05-28 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $93.94 — a volume-weighted average of daily closes over 58 sessions, not a true tick-by-tick VWAP. | +12.2% |
Price levels it has turned at before
HQY last closed at $105.41 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $106.50 | Resistance | 1.0% above the last close | turned there four times · 2024-11-25 to 2026-08-10 |
| $103.45 | Support | 1.9% below the last close | turned there three times · 2024-12-04 to 2025-05-22 |
| $100.48 | Support | 4.7% below the last close | turned there four times · 2025-05-13 to 2026-07-17 |
| $98.32 | Support | 6.7% below the last close | turned there 7 times · 2025-06-17 to 2026-07-07 |
| $116.12 | Resistance | 10.2% above the last close | turned there twice · 2025-02-13 to 2025-06-05 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part upward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $107.62.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
Alternate reading: The same swings also read as a five-part sequence in leg 4, which fails on a close below $100.00.
This reading has stood for 5 trading days, since 2026-08-17.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Near the 52-week high · in a Bollinger Band volatility squeeze · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.33 mean, 1=Strong Buy…5=Strong Sell) — 15 analysts
- Mean price target$118.53 range $105.00 – $135.00; median $120.00
Analyst estimates, as of 2026-08-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HQY
- Consensus EPS estimate$1.19 next reporting period, as of 2026-08-21
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Regulatory changes to HSA and CDB tax benefits could reduce consumer contributions and account growth","Competitive pressure from other HSA administrators and financial services providers entering the market","Dependence on employer adoption and retention of HSA/CDB benefits, which are subject to economic cycles and healthcare policy changes"]
What changed in the latest 10-Q
AI-assisted comparison of HQY's 10-Q filed 2026-05-28 against the prior one filed 2025-12-03.
Management's Discussion & Analysis (MD&A)
- Added:
- In newer filing (2026-05-28): Reference to Form 10-K for fiscal year ended January 31, 2026 (vs. January 31, 2025 in older filing)
- In newer filing (2026-05-28): Added 'and investing' to description of consumer decisions: 'make healthcare saving, spending, and investing decisions'
- In newer filing (2026-05-28): Updated account numbers as of April 30, 2026: 10.6 million HSAs with $37.1 billion in balances; 7.2 million complementary CDBs; 17.8 million Total Accounts
- In newer filing (2026-05-28): Updated market share metric to December 2025 (vs. June 2025 in older filing)
- In newer filing (2026-05-28): Updated Devenir report reference to '2025 Year-End' (vs. '2025 Midyear' in older filing)
- In newer filing (2026-05-28): Reordered revenue sources description from 'Network Partners, Clients, and members' to 'Clients, Network Partners, and members'
- In newer filing (2026-05-28): Changed custodial revenue description order from 'federally insured bank and credit union partners' listed first to 'insurance company partners' listed first
- Removed:
- In older filing (2025-12-03): Reference to Form 10-K for fiscal year ended January 31, 2025 (removed in newer filing)
- In older filing (2025-12-03): Phrase 'and spending' in consumer decision description (replaced with 'saving, spending, and investing')
- In older filing (2025-12-03): Account numbers as of October 31, 2025: 10.1 million HSAs with $34.4 billion in balances; 17.3 million Total Accounts
- In older filing (2025-12-03): '2025 Midyear Devenir HSA Research Report' reference and June 2025 market share metric
- In older filing (2025-12-03): Phrase 'marketplace platform' and 'the ability to earn wellness incentives' (simplified to just 'marketplace' in newer filing)
- In older filing (2025-12-03): Description of HSA as account for 'spend and save long-term' (changed to 'save, spend, and invest' in newer filing)
- In older filing (2025-12-03): Mention of 'benefits brokers and consultants' in Network Partners description
- In older filing (2025-12-03): Sentence about 'commuter benefits offering' leveraging ecosystem connectivity
- In older filing (2025-12-03): Entire section 'BenefitWallet HSA portfolio acquisition' describing fiscal 2025 acquisition details
- In older filing (2025-12-03): Reference to 'insurance company partners' in custodial revenue description (moved to first position in newer filing)
- Reworded:
- Section heading changed from 'Our acquisition and integration strategy' (older) to 'Our selective acquisition strategy' (newer)
- Older: 'We plan to continue this growth strategy' changed to newer: 'We expect to continue this growth strategy'
- Older: 'We have developed an internal capability to source, evaluate, and integrate acquired HSA portfolios' changed to newer: 'We have developed an internal capability to source, evaluate, and integrate acquisitions'
- Older description included 'benefits administrators, benefits brokers and consultants' in Network Partners; newer simplified to 'benefits administrators' without separate mention of brokers/consultants in that phrase
- Older: 'access to healthcare solutions through our marketplace platform' changed to newer: 'access to healthcare solutions through our marketplace'
- Newer filing adds detail about competitive landscape: 'Many of our competitors view their HSA businesses as non-core functions. We believe they may look to divest these assets and, in certain cases, may be limited from making acquisitions due to depository capital requirements.'
- Notes:
- Newer filing text appears truncated at end of 'Structural change in U.S. health insurance' section, preventing full comparison of that section
- Older filing text also appears truncated at end of 'Structural change in U.S. health insurance' section
- Account balance and HSA Assets figures represent period-end metrics and are expected to change between quarterly filings; these are updates rather than policy changes
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 5 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 5 sells ($2M) — 3 selling insiders
- Last 180 days0 buys · 5 sells ($2M) — 3 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-10. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HQY's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 6 matched disclosures for HQY from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
4 institutional 13F filers reported holding HQY as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 15,114,356
- Reported value $1,263,106,755
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
HQY had 4,167,244 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
HQY had 4.98% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.93 days to cover at the same settlement.
- Reported short interest (shares) 4,167,244
- Short interest (% of shares outstanding) 4.98%
- Prior settlement (shares) 5,036,614
- Reported change -17.26%
- Days to cover (reported) 5.93
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- WEX (WEX)
- Optum Financial (UNH)
- Further (HealthEquity)
- Alegeus
- Lively
- BenefitWallet
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HQY vs…
Frequently asked questions
What does HEALTHEQUITY INC (HQY) do?
HealthEquity is a technology-enabled services company that manages health savings accounts (HSAs) and other consumer-directed benefits (CDBs) such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA, and commuter benefits. The company provides a platform for consumers to save, spend, and invest healthcare dollars, integrated with employer-provided benefit programs and insurance ecosystems.
What sector is HEALTHEQUITY INC (HQY) in?
HEALTHEQUITY INC (HQY) is classified in the Health Care sector. Its industry is Healthcare benefits administration and tax-advantaged savings account services. It trades on NASDAQ.
Who are HEALTHEQUITY INC's (HQY) competitors?
Notable peers of HEALTHEQUITY INC (HQY) include WEX, Optum Financial, Further (HealthEquity), Alegeus and Lively. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in HQY?
Yes — we hold 6 matched STOCK Act disclosures for HQY from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is HEALTHEQUITY INC (HQY) overbought or oversold right now?
HEALTHEQUITY INC (HQY) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 61, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HQY come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.